Correlation Between Nuvectis Pharma and Icosavax
Can any of the company-specific risk be diversified away by investing in both Nuvectis Pharma and Icosavax at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvectis Pharma and Icosavax into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuvectis Pharma and Icosavax, you can compare the effects of market volatilities on Nuvectis Pharma and Icosavax and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvectis Pharma with a short position of Icosavax. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvectis Pharma and Icosavax.
Diversification Opportunities for Nuvectis Pharma and Icosavax
-0.33 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Nuvectis and Icosavax is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Nuvectis Pharma and Icosavax in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Icosavax and Nuvectis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvectis Pharma are associated (or correlated) with Icosavax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Icosavax has no effect on the direction of Nuvectis Pharma i.e., Nuvectis Pharma and Icosavax go up and down completely randomly.
Pair Corralation between Nuvectis Pharma and Icosavax
If you would invest 487.00 in Nuvectis Pharma on October 15, 2024 and sell it today you would earn a total of 94.00 from holding Nuvectis Pharma or generate 19.3% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 5.56% |
| Values | Daily Returns |
Nuvectis Pharma vs. Icosavax
Performance |
| Timeline |
| Nuvectis Pharma |
| Icosavax |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Nuvectis Pharma and Icosavax Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nuvectis Pharma and Icosavax
The main advantage of trading using opposite Nuvectis Pharma and Icosavax positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvectis Pharma position performs unexpectedly, Icosavax can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Icosavax will offset losses from the drop in Icosavax's long position.| Nuvectis Pharma vs. Replimune Group | Nuvectis Pharma vs. Lyra Therapeutics | Nuvectis Pharma vs. Kronos Bio | Nuvectis Pharma vs. Gossamer Bio |
| Icosavax vs. Terns Pharmaceuticals | Icosavax vs. Amylyx Pharmaceuticals | Icosavax vs. Acumen Pharmaceuticals | Icosavax vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |